Lexogen GmbH

Lexogen is a biotech company with unique proprietary expression profiling technologies that enable detailed analysis of the complete transcriptome as well as individual full length RNAs of interest. Lexogen was founded in 2007 with an investment by the AVV Investment Group. Lexogen is supported by the Austrian Research Promotion Agency FFG, the Austria Wirtschaftsservice AWS, INiTS and the Wirtschaftsagentur Wien. Lexogen is based at the Vienna BioCenter in Vienna, Austria, and has a subsidiary in New Hampshire, USA. 50 of Lexogen employees work in R&D.